This mini-review provides a critical synthesis of current findings on IL-36 and IL-38 in the context of atherosclerosis, myocardial ischaemia–reperfusion (I/R) injury, and post-percutaneous coronary intervention (PCI) outcomes. This evidence concerns the gene IL1F10 and atherosclerosis.